Pharma giant Eli Lilly said on Friday that it will pile $5.3 billion
into manufacturing its popular weight loss drugs, more than doubling its investment in a manufacturing facility in Lebanon, Indiana. The new spend brings the company’s total investment in the site to a whopping $9 billion, up from its original $3.7 billion commitment — making it now the largest manufacturing investment in the company’s history.
Advertisement
Print